Literature DB >> 15078955

Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Ronen Borenstein1, Oded Singer, Adi Moseri, Niza Frenkel.   

Abstract

The composite amplicon-6 vectors, which are derived from human herpesvirus 6 (HHV-6), can target hematopoietic cells. In the presence of the respective helper viruses, the amplicons are replicated by the rolling circle mechanism, yielding defective genomes of overall size 135 to 150 kb, composed of multiple repeats of units, containing the viral DNA replication origin, packaging signals, and the selected transgene(s). We report the use of amplicon-6 vectors designed for transgene expression in T cells. The selected transgenes included the green fluorescent protein marker, the herpes simplex virus type 1 glycoprotein D (gD), and the gD gene deleted in the transmembrane region (gDsec). The vectors were tested after electroporation and passage in T cells with or without helper HHV-6A superinfections. The results were as follows. (i)The vectors could be passaged both as cell-associated and as cell-free secreted virions infectious to new cells. (ii)The intact gD accumulated at the cell surface, whereas the gDsec was dispersed at internal locations of the cells or was secreted into the medium. (iii)Analyses of amplicon-6-gD expression by flow cytometry have shown significant expression in cultures with reiterated amplicons and helper viruses. The vector has spread to >60% of the cells, and the efficiency of expression per cell increased 15-fold, most likely due to the presence of concatemeric amplicon repeats. Current studies are designed to test whether amplicon-6 vectors can be used for gene therapy in lymphocytes and whether amplicon-6 vectors expressed in T cells and dendritic cells can induce strong cellular and humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078955      PMCID: PMC387683          DOI: 10.1128/jvi.78.9.4730-4743.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  86 in total

1.  Human herpesvirus 6 in serum and spinal fluid of patients with multiple sclerosis?

Authors:  Robert Beck; Heinz Wiendl; Gerhard Jahn; Arthur Melms; Frank Neipel
Journal:  Arch Neurol       Date:  2003-04

2.  Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis.

Authors:  N Akhyani; R Berti; M B Brennan; S S Soldan; J M Eaton; H F McFarland; S Jacobson
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

3.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  CD46 is a cellular receptor for human herpesvirus 6.

Authors:  F Santoro; P E Kennedy; G Locatelli; M S Malnati; E A Berger; P Lusso
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

5.  Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.

Authors:  D V Ablashi; H B Eastman; C B Owen; M M Roman; J Friedman; J B Zabriskie; D L Peterson; G R Pearson; J E Whitman
Journal:  J Clin Virol       Date:  2000-05       Impact factor: 3.168

6.  Human herpesvirus 6 in salivary glands.

Authors:  J D Fox; M Briggs; P A Ward; R S Tedder
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

7.  Human herpesviruses in chronic fatigue syndrome.

Authors:  H L Wallace; B Natelson; W Gause; J Hay
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

8.  Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome.

Authors:  D Di Luca; M Zorzenon; P Mirandola; R Colle; G A Botta; E Cassai
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Bone marrow transplant recipients harbor the B variant of human herpesvirus 6.

Authors:  N Frenkel; G C Katsafanas; L S Wyatt; T Yoshikawa; Y Asano
Journal:  Bone Marrow Transplant       Date:  1994-11       Impact factor: 5.483

View more
  6 in total

1.  Cloning human herpes virus 6A genome into bacterial artificial chromosomes and study of DNA replication intermediates.

Authors:  Ronen Borenstein; Niza Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

2.  Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes.

Authors:  Eyal Sharon; Ludmila Volchek; Niza Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-12       Impact factor: 11.205

3.  The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines.

Authors:  Ronen Borenstein; Haim Zeigerman; Niza Frenkel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

Review 4.  Microfluidic models for adoptive cell-mediated cancer immunotherapies.

Authors:  Giulia Adriani; Andrea Pavesi; Anthony T Tan; Antonio Bertoletti; Jean Paul Thiery; Roger D Kamm
Journal:  Drug Discov Today       Date:  2016-05-13       Impact factor: 7.851

Review 5.  Engineering lymphocyte subsets: tools, trials and tribulations.

Authors:  Carl H June; Bruce R Blazar; James L Riley
Journal:  Nat Rev Immunol       Date:  2009-10       Impact factor: 53.106

6.  Human Herpesvirus 6A Exhibits Restrictive Propagation with Limited Activation of the Protein Kinase R-eIF2α Stress Pathway.

Authors:  Eyal Sharon; Niza Frenkel
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.